Dr. Joseph Geraci, Ph.D., Named Chief Science Officer at Open Source Health Inc.
Mathematical Physicist and Medical Data Scientist To Lead Open Source Heath’s Medical Research, Data Science and Nanotechnology Development
Toronto, Ontario Canada – March 27, 2014: Open Source Health Inc., (“Open Source Health” / “the Company”) (CSE:OSH) a digital integrated healthcare company dedicated to advancing life-long solutions for women’s health and wellness is pleased to announce the appointment of Dr. Joseph Geraci as Chief Science Officer (“CSO”).
Dr. Geraci brings his unique expertise in data science, neuroscience, clinical biomarker development, and algorithm creation to Open Source Health. His work focuses on using mathematical methods to construct models of disease and wellness that go beyond the classical top-down clinical definitions, and it will bolster Open Source Health’s suite of patient care programs and strategic research initiatives. He will report directly to CEO, Sonya Satveit, as they oversee Open Source Health’s nanotechnology development and healthcare informatics outreach along with the Company’s competitive data strategy.
“Dr. Geraci brings a tremendous skillset to Open Source Health’s integrative health care initiatives,” stated Sonya Satveit, CEO of Open Source Health. “I am confident that with Dr. Geraci’s assistance we are going to achieve major breakthroughs in women’s healthcare while building a significant revenue stream for funded research.”
Dr. Geraci commented about joining the Open Source Health team, “Knowing that hormones have an integral impact on women’s health, my involvement with the Company is an exciting opportunity for me to advance the understanding of the interplay between hormone levels and biological markers to create truly innovative technologies that will assist women in taking control of their own vitality. I am thrilled to have the opportunity to apply my scientific expertise towards such a monumental endeavor.”
Dr. Joseph Geraci will continue to spend a portion of his time at Queen’s University, as an Assistant Professor in the Dept. of Pathology and Molecular Medicine and as a Scientific Associate at the University Health Network (UHN) in Psychiatry. His work at Queen’s is focused on cancer biomarker development and novel treatment approaches, whereas at UHN he is leading the advanced data analysis approaches for CANBIND – a cross Canada depression study funded by the Ontario Brain Institute, CIHR, Lundbeck, and Servier. Dr. Geraci’s clinical and scientific experience with depression will play a critical role during our exploration of several issues including postpartum mood disorders and in the development of the resulting technological devices and algorithms.
About Open Source Health:
Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health is set to lead the current healthcare revolution by capitalizing on the latest trends in: digital health, personalized health, social health, mobile health, and participatory medicine.
For more information, visit www.opensourcehealth.com
For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933
Forward Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of OSH, including, but not limited to, the uncertainty of the Transaction proceeding, the impact of general economic conditions, industry conditions, dependence upon regulatory and shareholder approvals, the execution of definitive documentation and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.